Les vulvo-vaginites de la petite fille en zone tropicale urbaine : aspects bactériologiques

Achi, Y.H. Faye-Kette; Sylla-Koko, D. F.; N'Douba-Kacou, A.; Akoua-Koffi, G.; Kouassi, A.B.; Cissé, L.; Bouzid, S.; Kouakou, K.; Dosso, Mireille

doi:10.1016/s0399-077x(05)81376-9

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results are similar to those of previous studies in the African region, which have reported rubella seropositive estimates of 72-99% in women of reproductive age, 7,[16][17][18][19][20][21][22][23][24] and 53-95% in pregnant women. 18,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] These serosurvey results and evidence from epidemiological investigations and CRS surveillance indicate that rubella virus is circulating on the African continent, causing rubella infections and CRS. 8,42 For pregnant women, rubella susceptibility is concerning because of the risk of CRS in the fetus.…”

Section: Discussionmentioning

confidence: 99%

Rubella immunity among pregnant women aged 15–44 years, Namibia, 2010

Jonas

Cardemil

Beukes³

et al. 2016

International Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Rubella immunity among pregnant women aged 15–44 years, Namibia, 2010

Jonas

Cardemil

Beukes³

et al. 2016

International Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Global rubella virus seropositivity estimates varies with WHO regions in pregnant women and women of child bearing age, with susceptible rates of > 5% [5]. Several studies from West Africa using ELISAs from different companies have recorded varying prevalence rates of rubella virus (RV) specific IgM (1.36-38.8%) and IgG (53.0%-95.7%) [6][7][8][9][10][11][12][13][14]. There are always varying percentages of non-immune pregnant women, and most of these studies did not identify specific risk factors.…”

Section: Introductionmentioning

confidence: 99%

Rubella virus IgM and IgG antibodies with avidity in pregnant women and outcomes at a tertiary facility in Ghana

et al. 2022

View full text Add to dashboard Cite

Background Congenital rubella syndrome (CRS) is a recognised cause of childhood deafness and blindness caused by the transplacental transmission of rubella virus during pregnancy. Women in the reproductive age group, and by extension their unborn babies may therefore be at increased risk. The prevalence of Rubella virus specific IgM and IgG antibodies, including IgG avidity, was determined in pregnant women attending the antenatal clinic at a Teaching Hospital in Ghana. Methods One hundred and forty-five women in their second and third trimesters of pregnancy from the outpatient clinic were recruited over a period of 2 months after written informed consent was obtained. Study participants completed a questionnaire and venous blood drawn for IgM, IgG, and avidity testing using SERION ELISA (SERION® Immunologics, Würzburg, Germany). Babies of mothers with positive or indeterminate IgM and low avidity IgG antibodies were offered specialist cardiological, ophthalmological or hearing assessment during follow up. Results One hundred and twenty-eight (88.3%) had only IgG antibodies, 5 (3.4%) had IgM and IgG antibodies, while 12 (8.3%) had no antibodies. No patient had IgM antibodies alone. Ten women (6.9%) had indeterminate levels of IgM antibodies. Majority of the women had high avidity IgG antibodies, while 5 (3.4%) had low avidity antibodies. No patient had IgM with low avidity antibodies. There was no statistical association between socio-demographic factors and the presence of IgM, IgG (low or high avidity) antibodies. Of all the children followed, none had the clinical definition of CRS. Conclusions Consistent with the World Health Organization elimination strategy for measles and rubella viruses, non-immune women in the reproductive age group should be vaccinated. The immunization programme should be expanded to include teenagers and adults. Though Congenital Rubella Syndrome was not detected, the risk still remains.

show abstract

Les vulvo-vaginites de la petite fille en zone tropicale urbaine : aspects bactériologiques

Cited by 2 publications

References 3 publications

Rubella immunity among pregnant women aged 15–44 years, Namibia, 2010

Rubella immunity among pregnant women aged 15–44 years, Namibia, 2010

Rubella virus IgM and IgG antibodies with avidity in pregnant women and outcomes at a tertiary facility in Ghana

Contact Info

Product

Resources

About